Swiss Medica, Inc.
OTC Bulletin Board : SWME

Swiss Medica, Inc.

August 05, 2005 06:00 ET

Swiss Medica Provides Third Quarter Store Count Guidance for O24'TM' Pain Neutralizer, O24 Fibromylagia'TM' and PMS Escape'TM'

TORONTO, ONTARIO--(CCNMatthews - Aug. 5, 2005) - Swiss Medica, Inc. (OTCBB:SWME) is pleased to reaffirm that the Company's flagship O24™ Pain Neutralizer product will be available in excess of 19,000 retail stores throughout the United States and Canada by September 30, 2005.

Management anticipates that the recently launched O24 Fibromyalgia™ will be available in approximately 14,000 retail stores across the United States by September 30, 2005. In addition, PMS Escape™ will be available in over 5,300 retail outlets throughout the United States by August 31, 2005.

Specific retail store locators for both O24™ Pain Neutralizer and O24 Fibromyalgia™ can be found at www.O24zone.com. Specific retail store locators will be available for PMS Escape™ by the end of August at www.pmsescape.com. Swiss Medica will continue its extensive and aggressive marketing, public relations, and sampling programs to support the increased national distribution for all three products.

About Swiss Medica, Inc.

Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com

Swiss Medica's flagship product, the O24™ Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.

Swiss Medica also manufactures PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.

Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.

Contact Information

  • Swiss Medica, Inc.
    David Jones
    Investor Relations Contact
    1 (866) 485-4243
    or
    Fusion Communications
    Dean Mailey
    Public Relations Contact
    (604) 218-6767
    dean@fusioncom.ca
    or
    Stern & Co.
    Stan Froelich, VP, Media Relations
    Financial Media Contact
    (212) 888-0044
    sfroelich@sternco.com